&w=3840&q=100)
Dividend stocks: Bharat Seats & 1 other stock to trade ex-date on July 2
The ex-date marks the day a stock starts trading without the eligibility for dividends, bonus shares, stock splits, or rights issues. This means that investors who purchase the stock on or after the ex-date will not be entitled to these benefits.
To be eligible, an investor must hold the stock before the ex-date. However, the final list of beneficiaries for dividends, stock splits, or rights issues is prepared by the company based on shareholders recorded at the close of the record date.
Investors should note that the ex-date and record date for these stocks are the same, making them a key focus in today's market.
Shares trading ex-date for dividend
Bharat Seats has declared a final dividend of ₹1.1 per share
"The board of directors has recommended dividend at 55 per cent i.e. ₹ 1.1 per equity share of ₹2 each of the company for the year ended March 31, 2025," the filing read.
Besides, Sika Interplant Systems declared a final dividend of ₹2.4 per share, according to corporate action data on BSE.
"The board of directors recommended a final dividend of ₹2.4 (Rupees Two and Forty paise only) per equity share of the company for the financial year ended March 31, 2025," the filing read.
A final dividend is the last dividend paid by a company for a financial year, declared after the annual financial results are finalised.
That apart, shares of Cera Sanitaryware, JSW Infrastructure and Polychem will be in focus today, July 1, 2025, as they will trade ex-dividend.
Cera Sanitaryware has declared a dividend of ₹65 per share, JSW Infrastructure has recommended ₹0.8 per share and Polychem has declared a final dividend of ₹20 per share.
What happens to the stock on ex-date?
On the ex-date, the stock price typically experiences a drop by the amount of the dividend or corporate action (such as stock splits or bonus issues) that is being distributed. This adjustment happens because investors who buy the stock on or after the ex-date do not receive the dividend.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
35 minutes ago
- Mint
Mahindra Holidays shares to be in focus on Friday after acquiring 100% stake in Finland-based real estate firm
Mahindra Group-owned hotel subsidiary, Mahindra Holidays & Resorts India, shares will be in focus of the stock market investors on Friday, 4 July 2025, after the company acquired a 100% stake in a Finland-based mutual real estate firm, Keskinainen Kiinteistcö Oy Salla Star, according to an exchange filing. The company acquired the Finnish firm for nearly ₹ 23.5 million, according to the filing data. 'We would like to inform you that Holiday Club Resorts Oy, incorporated in Finland, which in turn is a wholly owned subsidiary of Covington S.a.r.l., which in turn is a wholly owned subsidiary of MHR Holdings (Mauritius) Limited, which in turn is a wholly owned subsidiary of Mahindra Holidays & Resorts India Limited, has executed a Share Purchase Agreement (SPA) with shareholders of Keskinainen Kiinteistcö Oy Salla Star,, Finland to acquire 100% stake in KKOSS today i.e. 3 July 2025,' said Mahindra Holidays in the BSE filing. The Keskinainen Kiinteistö Oy Salla Star is a Finnish mutual real estate firm whose primary business is owning and managing a property located in 'Block 26' in the village of Markajarvi in Salla, Finland. The company makes an annual turnover of a little over ₹ 5.13 lakh as of the year ended 31 December 2024. The firm has a net worth of ₹ 2.37 lakh as of the same period, according to the BSE filing. The company disclosed that the 'acquisition doesn't fall within related party transaction(s).' However, the deal has been carried out through multiple subsidiaries of the Maindra Group firms. Mahindra Holidays & Resorts shares closed 0.80% higher at ₹ 341 after Thursday's stock market session, compared to ₹ 338.30 at the previous market close. The company announced the acquisition move after market operating hours on 3 July 2025. Mahindra Holidays & Resorts shares have given stock market investors more than 185% returns on their investment in the last five years. However, the stock is down 25% in the last one-year period. On a year-to-date (YTD) basis, the stock has lost 8.18% in 2025, and is trading 1.49% lower in the last five trading sessions. The company shares hit their year-high levels at ₹ 494.95 on 25 July 2024, while the year-low level was at ₹ 241 on 7 April 2025, according to the data collected from the BSE website. The hotel chain's market capitalisation (M-Cap) was at ₹ 6,888.78 crore as of the stock market close on Thursday, 3 July 2025. The BSE data also showed that the company's Price to Earnings (PE) ratio was greater than 50 for the previous four trailing quarters. This may likely mean that higher growth expectations from stock market investors, an asset-rich business, or maybe even a potential overvaluation in the current market. Read all stories by Anubhav Mukherjee Disclaimer: This story is for educational purposes only. The views and recommendations above are those of individual analysts or broking companies, not Mint. We advise investors to check with certified experts before making any investment decisions.
The Print
2 hours ago
- The Print
Stock markets decline on fag-end selling; financial stocks drag
The 50-share NSE Nifty declined by 48.10 points or 0.19 per cent to 25,405.30. The 30-share BSE Sensex dropped by 170.22 points or 0.20 per cent to settle at 83,239.47. The index opened higher and rose further by 440.4 points or 0.52 per cent to hit a high of 83,850.09. However, profit taking emerged in the last hour of trade dragging the barometer to a low of 83,186.74 in the pre-close session. Mumbai, Jul 3 (PTI) Benchmark stock indices Sensex and Nifty pared intra-day gains to close lower on Thursday due to last-hour selling in financial and metal shares. Among the Sensex firms, Kotak Mahindra Bank, Bajaj Finserv, Bajaj Finance, Adani Ports, Trent, State Bank of India, Titan and Tata Consultancy Services were the laggards. However, Maruti, Infosys, NTPC, Asian Paints, Eternal and Hindustan Unilever were among the biggest gainers. 'Markets traded volatile on the weekly expiry day and ended marginally lower, continuing the ongoing consolidation phase,' Ajit Mishra – SVP, Research, Religare Broking Ltd said. Sector-wise, the trend remained mixed — auto and pharma posted gains, while metal and realty were among the top losers, he added. The broader indices also mirrored this movement and closed on a flat note. The BSE smallcap gauge climbed 0.47 per cent while midcap index dipped 0.06 per cent. Among BSE sectoral indices, services dropped the most by 1.08 per cent, followed by metal (0.77 per cent), realty (0.61 per cent), telecommunication (0.55 per cent), utilities (0.48 per cent) and bankex (0.48 per cent). Healthcare, consumer discretionary, auto, consumer durables and oil & gas were the gainers. Vinod Nair, Head of Research, Geojit Investments Limited, said that investors remain watchful of developments surrounding the potential US-India trade agreement, with the 90-day pause nearing its end. FIIs have turned cautious in the recent days due to premium valuation. In Asian markets, South Korea's Kospi, Japan's Nikkei 225 index and Shanghai's SSE Composite index settled higher while Hong Kong's Hang Seng ended lower. European markets were trading on a mixed note. The US markets ended mostly higher on Wednesday. The Indian services sector growth touched a ten-month high in June aided by robust expansion in international sales and job creation, amid positive demand trends and ongoing improvement in sales, a monthly survey said on Thursday. The seasonally adjusted HSBC India Services PMI Business Activity Index rose from 58.8 in May to 60.4 in June, driven by sharp upturn in new business orders. In the Purchasing Managers' Index (PMI) parlance, a print above 50 means expansion, while a score below 50 denotes contraction. Global oil benchmark Brent crude declined 1.03 per cent to USD 68.40 a barrel. Foreign Institutional Investors (FIIs) offloaded equities worth Rs 1,561.62 crore on Wednesday, according to exchange data. On Wednesday, the BSE Sensex ended 287.60 points or 0.34 per cent lower at 83,409.69. The Nifty declined by 88.40 points or 0.35 per cent to settle at 25,453.40. PTI SUM MR MR This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.
&w=3840&q=100)
Business Standard
3 hours ago
- Business Standard
Carlyle Group may sell 10% stake in Piramal Pharma via block deals: Report
United States-based private equity firm Carlyle Group is planning to divest up to 10 per cent stake in Piramal Pharma through block deals, Moneycontrol reported on Thursday, citing sources. The sale could amount to ₹2,600-2,700 crore, the report added. Piramal Pharma sold 20 per cent of its stake to Carlyle Group in June 2020, in a deal worth ₹3,523 crore. According to stock exchange data, it held 18 per cent stake in the pharma firm as of March 31, 2025. Financial services firm Motilal Oswal has been roped in to facilitate the block deals, the report added. Piramal Pharma operates a diverse and global pharmaceutical business, providing a broad range of products and services. It includes Piramal Pharma Solutions (PPS), a fully integrated contract development and manufacturing organisation (CDMO); Piramal Critical Care (PCC), a complex hospital generics business; and the India Consumer Healthcare business, selling over-the-counter consumer and wellness products. Piramal Pharma Q4 result In the fourth quarter of FY25, Piramal Pharma posted a consolidated revenue from operations of ₹2,754 crore, marking an 8 per cent increase over the ₹2,552 crore recorded in the same quarter last year. The company's EBITDA (earnings before interest, tax, depreciation, and amortisation) also increased by 8 per cent year-on-year to ₹603 crore, up from ₹556 crore. Profit after tax (before exceptional items) came in at ₹154 crore, reflecting a 16 per cent rise compared to ₹132 crore in the corresponding period of the previous financial year. Shares of Piramal Pharma last traded at ₹202.4 apiece on the BSE at the close of the markets on Thursday.
